Emmanuel Papadakis
Stock Analyst at Deutsche Bank
(3.98)
# 1,789
Out of 4,581 analysts
1247
Total ratings
53.6%
Success rate
3.9%
Average return
Main Sectors:
Stocks Rated by Emmanuel Papadakis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: GSK GSK plc | Maintained: Hold | 1,950p → 2,000p | 1,968p | +1.65% | 169 | Jul 30, 2026 | |
| LON: AZN AstraZeneca PLC | Maintained: Sell | 11,500p | 12,810p | -10.23% | 190 | Jul 28, 2026 | |
| LON: 0QW0 argenx SE | Maintained: Buy | €900.00 | €751.00 | +19.84% | 35 | Jul 27, 2026 | |
| SWX: ROP Roche Holding AG | Maintained: Hold | CHF 340.00 | CHF 354.00 | -3.95% | 141 | Jul 24, 2026 | |
| SWX: NOVN Novartis AG | Maintained: Buy | CHF 140.00 | CHF 127.66 | +9.67% | 135 | Jul 22, 2026 | |
| STO: SOBI Swedish Orphan Biovitrum AB (publ) | Maintained: Buy | kr 285.00 → kr 515.00 | kr 474.20 | +8.60% | 18 | Jul 21, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 290.00 | kr 335.80 | -13.64% | 158 | Jul 20, 2026 | |
| EPA: SAN Sanofi | Maintained: Buy | €100.00 → €95.00 | €74.07 | +28.26% | 143 | Jun 15, 2026 | |
| ZLDPF Zealand Pharma A/S | Maintained: Hold | $42 → $46 | $46.53 | -1.74% | 7 | Jun 4, 2026 | |
| LON: 0MGB Genmab A/S | Maintained: Buy | kr 2,400 → kr 2,250 | kr 1,892 | +18.95% | 23 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 70.00 → CHF 65.00 | CHF 67.54 | -3.76% | 9 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 | $92.95 | +50.62% | 32 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $51.58 | - | 16 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €285.00 → €295.00 | €249.17 | +18.39% | 25 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $882.56 | - | 2 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €11.00 → €12.00 | €10.54 | +13.91% | 28 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €12.00 → €14.00 | €11.28 | n/a | 12 | Jul 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €22.00 | €24.04 | n/a | 13 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $44.85 | n/a | 4 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 1.00 | CHF 5.92 | n/a | 11 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $85 → $80 | $54.49 | n/a | 13 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1,210.02 | n/a | 1 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $14 | $3.53 | n/a | 6 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $8.15 | n/a | 2 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €95.00 → €124.00 | €163.10 | n/a | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $54.99 | n/a | 3 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $28.52 | n/a | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €44.00 | €51.35 | n/a | 1 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $125 → $57 | $27.72 | n/a | 2 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $53.22 | n/a | 5 | Apr 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $17.95 | n/a | 2 | Jul 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €80.00 | €48.32 | n/a | 31 | Jul 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €63.21 → €78.00 | €143.95 | n/a | 2 | Jan 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $158.83 | n/a | 4 | Dec 7, 2018 |
GSK plc
Jul 30, 2026
Maintained: Hold
Price Target: 1,950p → 2,000p
Current: 1,968p
Upside: +1.65%
AstraZeneca PLC
Jul 28, 2026
Maintained: Sell
Price Target: 11,500p
Current: 12,810p
Upside: -10.23%
argenx SE
Jul 27, 2026
Maintained: Buy
Price Target: €900.00
Current: €751.00
Upside: +19.84%
Roche Holding AG
Jul 24, 2026
Maintained: Hold
Price Target: CHF 340.00
Current: CHF 354.00
Upside: -3.95%
Novartis AG
Jul 22, 2026
Maintained: Buy
Price Target: CHF 140.00
Current: CHF 127.66
Upside: +9.67%
Swedish Orphan Biovitrum AB (publ)
Jul 21, 2026
Maintained: Buy
Price Target: kr 285.00 → kr 515.00
Current: kr 474.20
Upside: +8.60%
Novo Nordisk A/S
Jul 20, 2026
Maintained: Hold
Price Target: kr 290.00
Current: kr 335.80
Upside: -13.64%
Sanofi
Jun 15, 2026
Maintained: Buy
Price Target: €100.00 → €95.00
Current: €74.07
Upside: +28.26%
Zealand Pharma A/S
Jun 4, 2026
Maintained: Hold
Price Target: $42 → $46
Current: $46.53
Upside: -1.74%
Genmab A/S
May 11, 2026
Maintained: Buy
Price Target: kr 2,400 → kr 2,250
Current: kr 1,892
Upside: +18.95%
Apr 30, 2026
Maintained: Hold
Price Target: CHF 70.00 → CHF 65.00
Current: CHF 67.54
Upside: -3.76%
Mar 17, 2026
Maintained: Buy
Price Target: $140
Current: $92.95
Upside: +50.62%
Feb 23, 2026
Downgraded: Hold
Price Target: n/a
Current: $51.58
Upside: -
Dec 8, 2025
Maintained: Buy
Price Target: €285.00 → €295.00
Current: €249.17
Upside: +18.39%
Sep 11, 2025
Downgraded: Hold
Price Target: n/a
Current: $882.56
Upside: -
Aug 5, 2025
Maintained: Hold
Price Target: €11.00 → €12.00
Current: €10.54
Upside: +13.91%
Jul 28, 2025
Maintained: Buy
Price Target: €12.00 → €14.00
Current: €11.28
Upside: n/a
Apr 28, 2025
Maintained: Hold
Price Target: €22.00
Current: €24.04
Upside: n/a
Jan 30, 2025
Upgraded: Hold
Price Target: n/a
Current: $44.85
Upside: n/a
Nov 29, 2024
Maintained: Hold
Price Target: CHF 1.00
Current: CHF 5.92
Upside: n/a
Aug 6, 2024
Upgraded: Hold
Price Target: $85 → $80
Current: $54.49
Upside: n/a
Jul 17, 2024
Maintained: Hold
Price Target: n/a
Current: $1,210.02
Upside: n/a
Jul 2, 2024
Reiterated: Hold
Price Target: $8 → $14
Current: $3.53
Upside: n/a
Jun 18, 2024
Upgraded: Hold
Price Target: n/a
Current: $8.15
Upside: n/a
Aug 7, 2023
Maintained: Hold
Price Target: €95.00 → €124.00
Current: €163.10
Upside: n/a
Jan 18, 2023
Downgraded: Sell
Price Target: n/a
Current: $54.99
Upside: n/a
Nov 11, 2022
Downgraded: Hold
Price Target: n/a
Current: $28.52
Upside: n/a
Aug 9, 2022
Maintained: Hold
Price Target: €44.00
Current: €51.35
Upside: n/a
Aug 6, 2021
Downgraded: Hold
Price Target: $125 → $57
Current: $27.72
Upside: n/a
Apr 16, 2021
Maintained: Sell
Price Target: n/a
Current: $53.22
Upside: n/a
Jul 15, 2020
Reiterated: Hold
Price Target: n/a
Current: $17.95
Upside: n/a
Jul 14, 2020
Maintained: Buy
Price Target: €80.00
Current: €48.32
Upside: n/a
Jan 15, 2019
Maintained: Sell
Price Target: €63.21 → €78.00
Current: €143.95
Upside: n/a
Dec 7, 2018
Downgraded: Sell
Price Target: n/a
Current: $158.83
Upside: n/a